VMP1 enhances autophagy to mitigate cardiac fibroblast activation and reduce post-ischemia-reperfusion fibrosis
Cellular Signalling · 2025
DOI: 10.1016/j.cellsig.2025.112105 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular Signalling, 2025. Verfasst von Ya Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Sijing Hospital of Songjiang District, Shanghai, China; Department of Cardiology, Affiliated Hospital of Hebei University, …. Hauptthemen laut MEDLINE: Autophagy, Fibroblasts, Myocardial Reperfusion Injury, Membrane Proteins. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: Hebei Provincial Natural Science Foundation.
Abstract (Originalsprache)
BACKGROUND: Myocardial ischemia-reperfusion (I/R) injury contributes significantly to cardiac fibrosis, yet the regulatory mechanisms linking autophagy to fibroblast activation remain unclear. Vacuole membrane protein 1 (VMP1), an endoplasmic reticulum protein critical for autophagy initiation, has not been explored in this context. METHODS: We established a mouse model of I/R injury through left anterior descending (LAD) artery ligation, followed by reperfusion. Cardiac function was evaluated using echocardiography, while fibrosis and infarct size were assessed via Masson's trichrome and TTC staining. In vitro, primary cardiac fibroblasts were isolated and treated with TGF-β1 and PDGF-BB to simulate fibroblast activation. VMP1 was overexpressed using adenoviral vectors to investigate its effect on fibroblast activation, autophagic flux, and extracellular matrix (ECM) deposition. RESULTS: VMP1 expression was markedly downregulated in I/R-injured hearts and TGF-β1-stimulated fibroblasts. Overexpression of VMP1 enhanced autophagic flux (increased LC3-II/LC3-I, decreased p62) and suppressed fibroblast activation, reducing α-SMA and collagen I levels. Mechanistically, VMP1 inhibited mTOR phosphorylation, and alleviated endoplasmic reticulum stress. CONCLUSIONS: VMP1 mitigates cardiac fibrosis by enhancing autophagy and restraining fibroblast-to-myofibroblast transition, highlighting its therapeutic potential for post-I/R injury. Further studies should explore clinical translation of VMP1-targeted strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Sijing Hospital of Songjiang District, Shanghai, China; Department of Cardiology, Affiliated Hospital of Hebei University, Hebei, China.
- Department of Cardiology, Affiliated Hospital of Hebei University, Hebei, China.
- Department of Intensive Care Unit (ICU), SiJing Hospital of SongJiang District, Shanghai, China. Electronic address: dyzm3000@163.com.
- Medical Department, SiJing Hospital of SongJiang District, Shanghai, China. Electronic address: chenaj1975@163.com.
Förderung
- Hebei Provincial Natural Science Foundation
Zitieren
APA
Li, Y., Feng, C., Zu, Y., Long, P., & Chen, A. (2025). VMP1 enhances autophagy to mitigate cardiac fibroblast activation and reduce post-ischemia-reperfusion fibrosis. Cellular Signalling. https://doi.org/10.1016/j.cellsig.2025.112105
Vancouver
Li Y, Feng C, Zu Y, Long P, Chen A. VMP1 enhances autophagy to mitigate cardiac fibroblast activation and reduce post-ischemia-reperfusion fibrosis. Cellular Signalling. 2025. doi:10.1016/j.cellsig.2025.112105
BibTeX
@article{Li2025,
author = {Li, Ya and Feng, Cuina and Zu, Yugang and Long, Pan and Chen, Aijun},
title = {VMP1 enhances autophagy to mitigate cardiac fibroblast activation and reduce post-ischemia-reperfusion fibrosis},
journal = {Cellular Signalling},
year = {2025},
doi = {10.1016/j.cellsig.2025.112105}
}
EUVIMED